Johns Hopkins Medicine is collaborating with Germantown biotech Orgenesis to create a facility that will expand the institution’s ability to manufacture cell and gene therapy drugs.
RELATED POSTS
May 15, 2022
Since Wednesday, local economic and civic booster organization Baltimore Homecoming has been gathering the city’s most accomplished natives and expats for panels and curated field trips as part of Amplify...
May 14, 2022
Life sciences investment firm Catalio Capital Management has raised nearly $400 million for its next fund, its third and largest venture fund yet. Read the full article here.